2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one has been researched along with Prostatic Neoplasms, Castration-Resistant in 2 studies
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one: specific inhibitor of phosphatidylinositol 3-kinase; structure in first source
Prostatic Neoplasms, Castration-Resistant: Tumors or cancer of the PROSTATE which can grow in the presence of low or residual amount of androgen hormones such as TESTOSTERONE.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bai, S | 1 |
Chen, T | 1 |
Yu, X | 1 |
Luo, M | 1 |
Chen, X | 1 |
Lin, C | 1 |
Lai, Y | 1 |
Huang, H | 1 |
Kosaka, T | 1 |
Miyajima, A | 1 |
Shirotake, S | 1 |
Kikuchi, E | 1 |
Oya, M | 1 |
2 other studies available for 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Prostatic Neoplasms, Castration-Resistant
Article | Year |
---|---|
The specific killing effect of matrine on castration-resistant prostate cancer cells by targeting the Akt/FoxO3a signaling pathway.
Topics: Alkaloids; Antineoplastic Agents, Phytogenic; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell | 2017 |
Phosphorylated Akt up-regulates angiotensin II type-1 receptor expression in castration resistant prostate cancer.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Blood Proteins; Cell Line, Tumor; Chromones; Enzym | 2011 |